Skip to content
AnalystLens

TransUnion Quarterly Report for Q1 Ended Mar 31, 2024

Filing Date
Filed April 25, 2024
Period End
March 31, 2024
Security
TRU
In the record · 2016–202610-K1110-Q348-K130

TRU filed 11 annual reports (10-K), 34 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jun ’18Jun ’18
  2. Auditor change8-K · Feb ’20Feb ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 10-Q filed April 25, 2024. Cited figures are marked; the original filing is the authoritative source.

TransUnion reported first-quarter 2024 revenue of $1,021.2 milliona, up from $940.3 million a year earlier, and net income attributable to TransUnion of $65.1 million, compared with $52.6 million.

Diluted earnings per share were $0.33b versus $0.27. Consolidated Adjusted EBITDA rose to $358.2 million from $322.3 million, and the company reported Adjusted Diluted EPS of $0.92 versus $0.80. Growth was led by U.S. Markets revenue of $788.6 million (up 6.6%) and International gross revenue of $236.3 million (up 16.1%), with India a standout contributor.

Operating cash flow fell to $54.0 millionc from $77.4 million, which management attributed primarily to employee separation payments under the operating model optimization program. Restructuring expense of $18.2 million was recorded in the quarter, and the transformation plan is expected to cost $355.0 to $375.0 million pre-tax through 2025. Total debt was $5,330.6 million at March 31, 2024, against cash of $433.6 million, and the company refinanced Term Loan B-6 with a new $1.9 billion Term Loan B-7.

The filing discloses a material weakness in internal control over financial reporting, related to classification of costs between cost of services and selling, general and administrative expenses. It remained unremediated at March 31, 2024, so management concluded disclosure controls were not effective. The company also disclosed a CFPB lawsuit with $56.0 milliond accrued, plus a new CFPB NORA letter regarding dispute handling practices for which it could not estimate potential loss.

Key Highlights

  1. Revenue of $1,021.2 million, up from $940.3 million in Q1 2023, with growth in both U.S. Markets and International segments.
  2. Net income attributable to TransUnion of $65.1 million ($0.33 diluted EPS) versus $52.6 million ($0.27) a year earlier.
  3. Consolidated Adjusted EBITDA of $358.2 million, up from $322.3 million, with Consolidated Adjusted EBITDA margin of 35.1% versus 34.3%.
  4. Operating cash flow of $54.0 million, down from $77.4 million, mainly due to employee separation payments tied to the operating model optimization program.
  5. Restructuring expense of $18.2 million in the quarter; total transformation plan pre-tax expenses are expected at $355.0 to $375.0 million through 2025, with annual savings of $120.0 to $140.0 million upon completion.
  6. Total debt of $5,330.6 million and cash of $433.6 million at March 31, 2024; new $1.9 billion Term Loan B-7 refinanced Term Loan B-6.
  7. Disclosure controls were not effective due to an unremediated material weakness in cost classification between cost of services and SG&A; the CFPB lawsuit has $56.0 million accrued and a new CFPB NORA letter on dispute handling has no estimable loss range.

Financial Statements

Q1 FY2024 against Q1 FY2023

Line itemQ1 FY2024Q1 FY2023Change
Revenue$1.02B$940.30M+8.6%
SG&A Expenses$305.60M$284.60M+7.4%
Operating Expenses$864.10M$795.10M+8.7%
Operating Income$157.20M$145.20M+8.3%
Interest Expense$68.70M$71.80M−4.3%
Net Income$65.10M$52.60M+23.8%
EPS (Basic)$0.34$0.27+25.9%
EPS (Diluted)$0.33$0.27+22.2%
Shares Outstanding (Basic)194.10M193.00M+0.6%
Shares Outstanding (Diluted)195.30M193.90M+0.7%

Frequently Asked Questions

  1. How did TransUnion's revenue and profitability trend in the first quarter of 2024?

    Revenue rose to $1,021.2 million from $940.3 million, and net income attributable to TransUnion increased to $65.1 million from $52.6 million. Diluted EPS was $0.33 versus $0.27. Consolidated Adjusted EBITDA grew to $358.2 million from $322.3 million.

  2. Why did operating cash flow decline this quarter?

    Cash provided by operating activities was $54.0 million versus $77.4 million a year earlier. The filing attributes the decrease primarily to employee separation payments made in connection with the operating model optimization program.

  3. What regulatory and legal risks does the filing highlight?

    The company has accrued $56.0 million for a CFPB lawsuit and states a reasonable possibility of a loss above that amount, which could have a material adverse effect. In March 2024 it also received a CFPB NORA letter regarding dispute handling practices; the company cannot reasonably estimate the potential loss from that matter.

  4. Are there control weaknesses investors should know about?

    Yes. Management concluded that disclosure controls and internal control over financial reporting were not effective at March 31, 2024, due to a material weakness in classifying certain costs between cost of services and selling, general and administrative expenses. Remediation is in progress, and the weakness remained unremediated at quarter end.

  5. What is the company's debt and liquidity position?

    Total debt was $5,330.6 million and cash and cash equivalents were $433.6 million at March 31, 2024. The $600.0 million revolving credit facility had no outstanding balance, with $598.8 million available. The company stated it was in compliance with all debt covenants.